Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers

A Phase I Hexaminolevulinate (HAL) Dose-Finding Study Applying Different Formulations to the Cervix in Healthy Volunteers

The purpose of the study is to determine the most effective formulation of HAL for release of hexaminolevulinate to the cervical epithelium at different doses.

Inclusion Criteria:

• Healthy, pre-menopausal female volunteers

Exclusion Criteria:

• Acute or chronic disease which could influence the study results